| Challenges in validation of combination treatment strategies for CRC using patient-derived organoids | Journal of experimental & clinical cancer research |  | | 2024 | 47 | 80 |
|
| Personalised drug combination platform for effective colorectal cancer treatment | |  | | 2023 | 441 | 142 |
|
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma | Journal of experimental & clinical cancer research |  | | 2023 | 186 | 112 |
|
| FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells | Cancers |  | | 2022 | 260 | 236 |
|
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology |  | | 2020 | 449 | 204 |
|
| Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment | Molecules |  | | 2020 | 391 | 362 |
|
| Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma | Cancers |  | | 2020 | 352 | 391 |
|
| Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering | Cancers |  | | 2019 | 549 | 355 |
|
| Investigating the mechanism of enhanced cytotoxic activity of optimized combination therapies for cancer treatment | |  | | 2017 | 99 | 7 |
|